J. Goldman & CO LP Seelos Therapeutics, Inc. Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $85,860 - $128,520	-54,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $3.09 Million - $5.28 Million	-1,828,263 Reduced 97.13%	54,000 $130,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $4.84 Million - $11.6 Million	1,835,013 Added 3883.63%	1,882,263 $4.97 Million
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $63,787 - $235,777	47,250 New	47,250 $236,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.